ACADIA PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Acadia Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 166M shares, a 1.28% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 164K shares, a 1.32% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 162K shares, a 0.74% increase from 2021.
  • Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 160K shares, a 2.01% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 166M +2.09M +1.28% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 165M +2.54M +1.56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 164K +2.14K +1.32% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 164K +2.38K +1.47% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 163M +163M +101016% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 162M +1.03M +0.64% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 162K Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 162K +1.19K +0.74% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 162K +1.23K +0.77% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 161M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 161K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 160K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.